
Medtronic PLC MDT
$ 86.29
0.0%
Quarterly report 2025-Q4
added 02-24-2026
Medtronic PLC Accounts Receivables 2011-2026 | MDT
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables Medtronic PLC
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.52 B | 6.13 B | 6 B | 5.55 B | 5.46 B | 4.64 B | 6.22 B | 5.99 B | 5.59 B | 5.56 B | 5.11 B | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.52 B | 4.64 B | 5.71 B |
Quarterly Accounts Receivables Medtronic PLC
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.36 B | 6.39 B | 6.26 B | 6.52 B | 6.12 B | 6.26 B | 6.01 B | 6.13 B | 5.97 B | 5.93 B | 5.81 B | 6 B | 5.45 B | 5.63 B | 5.31 B | 5.55 B | 5.22 B | 5.49 B | 5.43 B | 5.46 B | 6.25 B | 5.35 B | 4.88 B | 4.64 B | 5.85 B | 6.12 B | 5.89 B | 6.22 B | 5.78 B | 5.74 B | 5.67 B | 5.99 B | 5.45 B | 5.75 B | 5.78 B | 5.59 B | 4.86 B | 5.66 B | 5.36 B | 5.56 B | - | 5.04 B | 4.81 B | 5.11 B | - | - | - | 3.81 B | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.52 B | 3.81 B | 5.65 B |
Accounts Receivables of other stocks in the Medical devices industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
11.4 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
371 M | $ 12.03 | -0.33 % | $ 1.63 B | ||
|
Allied Healthcare Products
AHPI
|
2.37 M | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
6.55 M | $ 9.06 | -3.41 % | $ 257 M | ||
|
Bruker Corporation
BRKR
|
566 M | $ 36.22 | -1.42 % | $ 5.4 K | ||
|
Apollo Endosurgery
APEN
|
15 M | - | - | $ 475 M | ||
|
OrthoPediatrics Corp.
KIDS
|
53.8 M | $ 15.68 | -1.63 % | $ 368 M | ||
|
Avinger
AVGR
|
1.01 M | - | -20.74 % | $ 369 K | ||
|
Align Technology
ALGN
|
996 M | $ 166.59 | -3.07 % | $ 12.5 B | ||
|
AxoGen
AXGN
|
26.2 M | $ 30.87 | -5.44 % | $ 1.42 B | ||
|
Axonics Modulation Technologies
AXNX
|
44.8 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
1.73 M | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
17.9 M | $ 3.44 | -2.0 % | $ 129 M | ||
|
Butterfly Network
BFLY
|
20.8 M | $ 4.01 | -3.14 % | $ 849 M | ||
|
Cytosorbents Corporation
CTSO
|
7.55 M | $ 0.58 | -1.69 % | $ 36.1 M | ||
|
TELA Bio
TELA
|
10.3 M | $ 0.67 | 5.89 % | $ 31.5 M | ||
|
BIOLASE
BIOL
|
5.48 M | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
11.7 M | $ 9.63 | -0.72 % | $ 345 M | ||
|
BioSig Technologies
BSGM
|
109 K | - | 37.08 % | $ 85.7 M | ||
|
Alphatec Holdings
ATEC
|
97.3 M | $ 11.14 | 1.55 % | $ 1.67 B | ||
|
CONMED Corporation
CNMD
|
248 M | $ 34.09 | 0.07 % | $ 1.06 B | ||
|
Edwards Lifesciences Corporation
EW
|
660 M | $ 80.75 | -0.49 % | $ 47.2 B | ||
|
Globus Medical
GMED
|
679 M | $ 90.0 | 1.55 % | $ 12.2 B | ||
|
Helius Medical Technologies
HSDT
|
117 K | $ 1.74 | -8.38 % | $ 1.06 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
272 M | $ 9.32 | 0.11 % | $ 718 M | ||
|
Inspire Medical Systems
INSP
|
120 M | $ 54.12 | -0.01 % | $ 1.59 B | ||
|
Conformis
CFMS
|
9.77 M | - | - | $ 16.4 M | ||
|
IRIDEX Corporation
IRIX
|
7.61 M | $ 1.0 | 0.34 % | $ 16.9 M | ||
|
Integer Holdings Corporation
ITGR
|
346 M | $ 85.59 | -0.04 % | $ 2.97 B | ||
|
LENSAR
LNSR
|
6.38 M | $ 5.85 | -0.68 % | $ 70 M | ||
|
Cardiovascular Systems
CSII
|
39.7 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
43.1 M | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
2.8 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
1.91 M | - | - | $ 10.2 M | ||
|
Myomo
MYO
|
4.1 M | $ 0.66 | -5.67 % | $ 27.6 M |